Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$250,482
-$7,239 QoQ
Shares Held
361,969
0.0% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 103 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Casdin Capital, LLC holds $705,487,766 across 26 Biotechnology names. TNYA ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $250,645,634 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
14,418,574 | $143,464,811 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $56,635,000 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
1,840,000 | $35,328,000 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $32,170,500 | |
| 6 | NGNE |
Neurogene Inc.
|
1,420,361 | $28,634,477 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,000 | $24,815,250 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
758,857 | $22,651,881 |
All Filings in TNYA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $250,482 | 361,969 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $257,721 | 361,969 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $586,389 | 361,969 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $221,163 | 361,969 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,837,793 | 6,732,971 | Shares | Sole | 2025-05-15 | |
| 2025-03-04 | $2,962,507 | 6,732,971 | Shares | Sole | 2025-03-07 | |
| 2024-12-31 | $9,628,148 | 6,732,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,994,634 | 6,732,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,872,210 | 6,732,971 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $35,213,438 | 6,732,971 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,675,661 | 6,381,377 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,272,511 | 6,381,377 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $37,458,682 | 6,381,377 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,324,751 | 6,078,860 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $12,218,508 | 6,078,860 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,401,772 | 3,586,818 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,193,785 | 3,586,818 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $42,252,716 | 3,586,818 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $67,970,201 | 3,586,818 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $74,067,791 | 3,586,818 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||